Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Elanco Animal Health Inc (NY: ELAN ) 13.56 -0.38 (-2.73%) Official Closing Price Updated: 7:00 PM EDT, Jul 9, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Elanco Animal Health Inc < Previous 1 2 3 4 5 Next > Why Kindred Biosciences Stock Skyrocketed Today June 16, 2021 The pet therapeutics pioneer is being scooped up by a global animal health leader. Via The Motley Fool Why Kindred Biosciences, Aprea, Catabasis And Inhibikase Are Moving Today June 16, 2021 Kindred Biosciences, Inc. (NASDAQ: KIN), Aprea Therapeutics, Inc. (NASDAQ: APRE), Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) and Inhibikase Therapeutics, Inc. (NASDAQ: IKT)... Via Benzinga Mid-Day Market Update: Dow Falls 40 Points; Aprea Therapeutics Shares Surge June 16, 2021 Midway through trading Wednesday, the Dow traded down 0.12% to 34,259.48 while the NASDAQ rose 0.20% to 14,100.31. The S&P also fell, dropping 0.05% to 4,244.41. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities Elanco Is Looking To Challenge Zoetis, Will The $440 Million Kindred Buyout Help? June 16, 2021 Elanco Animal Health said Wednesday it would buy Kindred Biosciences for roughly $440 million, sending KIN stock soaring. Via Investor's Business Daily Mid-Morning Market Update: Markets Mixed; Elanco Animal Health To Acquire Kindred Biosciences June 16, 2021 Following the market opening Wednesday, the Dow traded down 0.15% to 34,247.35 while the NASDAQ rose 0.36% to 14,123.49. The S&P also fell, dropping 0.01% to 4,246.07. The U.S... Via Benzinga Topics Stocks Exposures US Equities Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge May 01, 2021 Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... Via Benzinga Exposures Product Safety Analyzing The Price Action In Elanco Animal Health Stock Today April 15, 2021 Elanco Animal Health's Stock Price And Volume Action Elanco Animal Health's (NYSE: Via Benzinga Kindred Biosciences Stock Jumps On $440M Elanco Animal Buyout Deal June 16, 2021 Elanco Animal Health Incorporated (NYSE: ELAN) has agreed to acquire Kindred Biosciences Inc (NASDAQ: KIN) for $9.25 per share, or approximately $440 million... Via Benzinga Elanco Animal Health's Debt Overview June 15, 2021 Over the past three months, shares of Elanco Animal Health (NYSE:ELAN) rose by 14.38%. Before we understand the importance of debt, let us look at how much debt Elanco... Via Benzinga Elanco To Exit Three Manufacturing Sites To Streamline Footprint June 09, 2021 Following the acquisition of Bayer Animal Health, Elanco Animal Health Incorporated (NYSE: ELAN) has agreed to sell its sites in Shawnee, Kansas, and Speke,... Via Benzinga The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying May 21, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) Alexion Pharmaceuticals, Inc... Via Benzinga The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics May 19, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18) Alexion Pharmaceuticals, Inc... Via Benzinga Q1 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios May 18, 2021 The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and... Via Benzinga The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO May 18, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc... Via Benzinga Exposures COVID-19 Last Week's Notable Insider Buys: Activision, Avis Budget, Energy Transfer And More May 15, 2021 Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty or are near all-time highs. A couple of chief executive officers and... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2021 May 11, 2021 Upgrades For CEVA Inc (NASDAQ:CEVA), Barclays upgraded the previous rating of Equal-Weight to Overweight. For the first quarter, CEVA had an EPS of $0.01, compared to year... Via Benzinga ELANCO ANIMAL HEALTH INC (ELAN) Q1 2021 Earnings Call Transcript May 07, 2021 ELAN earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial Elanco Shares Rise After Q1 Earnings Exceed Expectations, Raises FY21 Outlook May 07, 2021 Elanco Animal Health Inc (NYSE: ELAN) has reported Q1 EPS of $0.37 higher than $0.13 reported a year ago. It surpassed analysts' estimate of $0.23 and... Via Benzinga Earnings Preview for Elanco Animal Health May 06, 2021 Elanco Animal Health (NYSE:ELAN) will be releasing its next round of earnings this Friday, May 07. For all of the relevant information, here is your guide for Friday's Q1 earnings... Via Benzinga A Product Recall Crashed Elanco's Stock. Is This a Buying Opportunity? April 27, 2021 Elanco's share price has come under pressure amid new concerns over a key product. Via The Motley Fool The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs May 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... Via Benzinga Earnings Scheduled For May 7, 2021 May 07, 2021 Companies Reporting Before The Bell • Cronos Group (NASDAQ:CRON) is likely to report earnings for its first quarter. • Eaton Vance Municipal (NYSE:ETX) is... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 15, 2021 April 15, 2021 Upgrades According to JP Morgan, the prior rating for Vipshop Holdings Ltd (NYSE:VIPS) was changed from Neutral to Overweight. In the fourth quarter, Vipshop Holdings... Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.